BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 38217037)

  • 1. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment.
    Hua Y; Yang S; Zhang Y; Li J; Wang M; Yeerkenbieke P; Liao Q; Liu Q
    J Exp Clin Cancer Res; 2024 Jan; 43(1):19. PubMed ID: 38217037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.
    Zhu W; Liu X; Yang L; He Q; Huang D; Tan X
    Eur J Pharmacol; 2023 Dec; 961():176124. PubMed ID: 37925133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
    Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
    ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron metabolism: State of the art in hypoxic cancer cell biology.
    Liu S; Cao X; Wang D; Zhu H
    Arch Biochem Biophys; 2022 Jul; 723():109199. PubMed ID: 35398290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic regulation of ferroptosis in the tumor microenvironment.
    Mbah NE; Lyssiotis CA
    J Biol Chem; 2022 Mar; 298(3):101617. PubMed ID: 35065965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis of immune cells in the tumor microenvironment.
    Kim R; Taylor D; Vonderheide RH; Gabrilovich DI
    Trends Pharmacol Sci; 2023 Aug; 44(8):542-552. PubMed ID: 37380530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy.
    Liu Y; Duan C; Dai R; Zeng Y
    Front Cell Dev Biol; 2021; 9():739392. PubMed ID: 34796174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging mechanisms and targeted therapy of ferroptosis in cancer.
    Wang H; Cheng Y; Mao C; Liu S; Xiao D; Huang J; Tao Y
    Mol Ther; 2021 Jul; 29(7):2185-2208. PubMed ID: 33794363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
    Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy.
    Xu H; Ye D; Ren M; Zhang H; Bi F
    Trends Mol Med; 2021 Sep; 27(9):856-867. PubMed ID: 34312075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis-mediated immune responses in cancer.
    Qi D; Peng M
    Front Immunol; 2023; 14():1188365. PubMed ID: 37325669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative role of ferroptosis in gastric cancer: a review.
    Wang L; Wang H
    Eur J Cancer Prev; 2023 Nov; 32(6):575-583. PubMed ID: 37318883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.
    Lei G; Zhuang L; Gan B
    Cancer Cell; 2024 Apr; 42(4):513-534. PubMed ID: 38593779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment.
    Zhao X; Lian X; Xie J; Liu G
    Redox Biol; 2023 Jun; 62():102678. PubMed ID: 36940607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
    Gu X; Liu Y; Dai X; Yang YG; Zhang X
    Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed Cell Death Tunes Tumor Immunity.
    Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
    Front Immunol; 2022; 13():847345. PubMed ID: 35432318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental Determinants of Ferroptosis in Cancer.
    Setayeshpour Y; Lee Y; Chi JT
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
    Zhu L; Meng D; Wang X; Chen X
    ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHKG2 regulates RSL3-induced ferroptosis in Helicobacter pylori related gastric cancer.
    Zhu W; Liu D; Lu Y; Sun J; Zhu J; Xing Y; Ma X; Wang Y; Ji M; Jia Y
    Arch Biochem Biophys; 2023 May; 740():109560. PubMed ID: 36948350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
    Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
    Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.